Background and Objective: Platelets abundantly express glycoprotein CD36 with thrombospondin-1 (TSP1) and oxidized low-density lipoprotein (oxLDL) as proposed ligands. How these agents promote platelet activation is still poorly understood. Methods and Results: Both TSP1 and oxLDL caused limited activation of platelets in suspension. However, immobilized TSP1 and oxLDL, but not LDL, strongly supported platelet adhesion and spreading with a major role of CD36. Platelet spreading was accompanied by potent Ca2+ rises, and resulted in exposure of P-selectin and integrin activation, all in a CD36-dependent manner with additional contributions of alpha(IIb)beta(3) and ADP receptor stimulation. Signaling responses via CD36 involved activation of t...
© 2013 by The American Society of Hematology. Oxidized low-density lipoproteins (oxLDL) generated in...
Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative ...
oxLDL binds platelet CD36 to stimulate tyrosine kinase– and PKC-dependent activation of NOX2 and gen...
Background and Objective: Platelets abundantly express glycoprotein CD36 with thrombospondin-1 (TSP1...
Objective Platelets abundantly express the membrane receptor CD36 and store its ligand thrombospondi...
Dyslipidemia is a risk factor for clinically significant thrombotic events. In this condition, scave...
The oxidation of low density lipoproteins (LDL) may contribute to platelet hyperactivity and thrombo...
Prostacyclin (PGI2) controls platelet activation and thrombosis through a cyclic adenosine monophosp...
©2020 Ferrata Storti Foundation Prostacyclin (PGI2) controls platelet activation and thrombosis thro...
<div><p>Specific oxidized phospholipids (oxPC<sub>CD36</sub>) promote platelet hyper-reactivity and ...
CD36 is a scavenger receptor expressed on a wide variety of cells including platelets. It recognizes...
Type 2 diabetes is characterized by increased plasma triglyceride levels and a fourfold increase in ...
Oxidized low-density lipoprotein (oxLDL) promotes unregulated platelet activation in dyslipidemic di...
<p>Oxidized low-density lipoprotein (oxLDL) and associated oxidized phosphocholine-headgroup phospho...
© 2013 by The American Society of Hematology. Oxidized low-density lipoproteins (oxLDL) generated in...
Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative ...
oxLDL binds platelet CD36 to stimulate tyrosine kinase– and PKC-dependent activation of NOX2 and gen...
Background and Objective: Platelets abundantly express glycoprotein CD36 with thrombospondin-1 (TSP1...
Objective Platelets abundantly express the membrane receptor CD36 and store its ligand thrombospondi...
Dyslipidemia is a risk factor for clinically significant thrombotic events. In this condition, scave...
The oxidation of low density lipoproteins (LDL) may contribute to platelet hyperactivity and thrombo...
Prostacyclin (PGI2) controls platelet activation and thrombosis through a cyclic adenosine monophosp...
©2020 Ferrata Storti Foundation Prostacyclin (PGI2) controls platelet activation and thrombosis thro...
<div><p>Specific oxidized phospholipids (oxPC<sub>CD36</sub>) promote platelet hyper-reactivity and ...
CD36 is a scavenger receptor expressed on a wide variety of cells including platelets. It recognizes...
Type 2 diabetes is characterized by increased plasma triglyceride levels and a fourfold increase in ...
Oxidized low-density lipoprotein (oxLDL) promotes unregulated platelet activation in dyslipidemic di...
<p>Oxidized low-density lipoprotein (oxLDL) and associated oxidized phosphocholine-headgroup phospho...
© 2013 by The American Society of Hematology. Oxidized low-density lipoproteins (oxLDL) generated in...
Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative ...
oxLDL binds platelet CD36 to stimulate tyrosine kinase– and PKC-dependent activation of NOX2 and gen...